Emilio Poggio

Dr. Emilio Poggio

Transplant Surgery
2050 East 96th Street, 
Cleveland, OH 
On Staff At
2050 East 96th Street, 
Cleveland, OH 
OverviewInsuranceLocationsClinical Research

Overview

Emilio Poggio is a Transplant Surgeon in Cleveland, Ohio. Dr. Poggio is rated as an Experienced provider by MediFind in the treatment of Magnesium Deficiency. His top areas of expertise are Hepatitis, Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Kidney Transplant, and Nephrectomy.

His clinical research consists of co-authoring 132 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
Cleveland Clinic
Specialties
Transplant Surgery
Licenses
Internal Medicine in OH
Board Certifications
American Board Of Internal Medicine, 2003
Fellowships
Fundacion Favaloro
Hospital Affiliations
Marymount Hospital
Cleveland Clinic
Akron General Medical Center
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Cleveland Clinic Main Campus
2050 East 96th Street, Cleveland, OH 44106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Treg Adoptive Therapy in Subclinical Inflammation in Kidney Transplantation (CTOT-21)
Treg Adoptive Therapy in Subclinical Inflammation in Kidney Transplantation (CTOT-21)
Enrollment Status: Completed
Publish Date: April 09, 2025
Intervention Type: Procedure, Drug, Biological
Study Phase: Phase 1/Phase 2
Regulatory T Cell Modulation in Kidney Transplantation With Biologic Blockade of Dual Effector Pathways, CD28 and IL-6 (CTOT-24)
Regulatory T Cell Modulation in Kidney Transplantation With Biologic Blockade of Dual Effector Pathways, CD28 and IL-6 (CTOT-24)
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug, Biological
Study Phase: Phase 1/Phase 2
Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry
Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2023
Intervention Type: Diagnostic test, Other
Randomized Controlled Trial of Infliximab (Remicade®) Induction Therapy for Deceased Donor Kidney Transplant Recipients (CTOT-19)
Randomized Controlled Trial of Infliximab (Remicade®) Induction Therapy for Deceased Donor Kidney Transplant Recipients (CTOT-19)
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug, Biological
Study Drugs: Infliximab, Methylprednisolone, Mycophenolate Mofetil, Tacrolimus, Thymoglobulin®, Acetaminophen, Loratadine, Prednisone, Diphenhydramine
Study Phase: Phase 2
View 3 Less Clinical Trials

132 Total Publications

Outcomes of Deceased Donor Kidney Transplants Allocated Out of Sequence in the United States.
Outcomes of Deceased Donor Kidney Transplants Allocated Out of Sequence in the United States.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: July 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Poggio's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile